C84.34 Lymphoepithelioid lymphoma, lymph nodes of axilla and upper limb

Name of the Condition

• Lymphoepithelioid lymphoma, lymph nodes of axilla and upper limb (ICD-10 Code: C84.34)

Summary

Lymphoepithelioid lymphoma, lymph nodes of axilla and upper limb, is a rare subtype of mature T-cell lymphoma characterized by a distinctive histological pattern of epithelioid histiocytes and small lymphocytes. It typically presents as localized lymphadenopathy in the axillary and upper limb lymph nodes and may involve extranodal sites. The condition is part of the broader category of peripheral T-cell lymphomas and is distinguished by its unique cellular composition, though its clinical behavior can vary.

Causes

The exact cause of lymphoepithelioid lymphoma is not fully understood. It is believed to involve genetic alterations in T-lymphocytes, leading to abnormal proliferation and tissue infiltration. Chronic antigen stimulation or immune dysregulation may contribute to its development, though specific triggers remain unclear. No consistent association with viral infections has been established.

Risk Factors

• Age: More common in adults, particularly those over 50.
• Immunosuppression: Conditions or treatments that weaken the immune system may increase risk.
• Genetic predisposition: Family history of lymphoma or related disorders.
• Ethnicity: Some studies suggest higher prevalence in certain populations, though data is limited.

Symptoms

• Painless swelling of lymph nodes (lymphadenopathy) in the axilla or upper limb.
• Possible systemic symptoms such as fever, night sweats, or weight loss in advanced cases.
• Fatigue or generalized weakness.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI) to assess lymph node involvement, and histopathological examination of biopsy tissue. Immunohistochemistry and molecular testing may be used to confirm the T-cell origin and rule out other lymphoma subtypes. Staging helps determine the extent of disease.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma. Options may include chemotherapy, targeted therapy, or radiation therapy for localized disease. Clinical trials or immunotherapy may be considered for refractory cases. Treatment plans are individualized based on patient health and disease characteristics.

Prognosis and Follow-Up

Prognosis varies based on disease stage, response to treatment, and overall health. Regular follow-up with imaging and clinical assessments is recommended to monitor for recurrence or progression. Long-term surveillance helps manage potential late effects of therapy.

Complications

• Disease progression or transformation to a more aggressive lymphoma.
• Treatment-related side effects, such as infection risk from immunosuppression.
• Lymphedema or functional impairment in the affected limb.

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known immunosuppressive factors, such as excessive alcohol or smoking.
• Stay up-to-date with vaccinations to reduce infection risk.

When to Seek Professional Help

Seek medical attention for persistent, unexplained lymph node swelling, systemic symptoms (e.g., fever, weight loss), or worsening fatigue. Early evaluation is important for timely diagnosis and management.

Tips for Medical Coders

Document the specific anatomical location (axilla and upper limb lymph nodes) to support code assignment. Include details on biopsy confirmation, staging, and treatment to ensure accurate coding and reflect the clinical complexity of the condition.